Monografie
Novel insights into the role of microRNAs in chemoresistance, tumor progression and cancer therapy
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Diss., 2013
- Identifier
-
1045153052
Thema
Krebs; Onkologie; Hochschulschrift
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
Targeted RNAi and pDNA based therapy for gastrointestinal tumors
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Treatment of cancer with combined chemo-gene therapy based on TNFα polyplexes and liposomal doxorubicine
Development of novel combinatorial treatment strategies to overcome resistance in breast cancer
Molecular imaging and radionuclide therapy in non-thyroidal tumors after mesenchymal stem cell- mediated sodium/iodide symporter (NIS) gene transfer
Molecularly targeted imaging and radionuclide therapy of non-thyroidal tumors following viral and non-viral sodium iodide symporter (NIS) gene delivery
Molecular evolution assays reveal novel targets and mechanisms of drug resistance
Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
Non-covalent dendrimer- and polymer-based modifications of adenovirus capsids for enhanced transduction of cancer cells
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities
Proton-sponge activity and receptor-targeting of sequence-defined nucleic acid carriers
Biocompatible and precise branched oligomers for pDNA and siRNA delivery
Targeted RNAi and pDNA based therapy for gastrointestinal tumors
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Treatment of cancer with combined chemo-gene therapy based on TNFα polyplexes and liposomal doxorubicine
Development of novel combinatorial treatment strategies to overcome resistance in breast cancer
Molecular imaging and radionuclide therapy in non-thyroidal tumors after mesenchymal stem cell- mediated sodium/iodide symporter (NIS) gene transfer
Molecularly targeted imaging and radionuclide therapy of non-thyroidal tumors following viral and non-viral sodium iodide symporter (NIS) gene delivery
Molecular evolution assays reveal novel targets and mechanisms of drug resistance
Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
Non-covalent dendrimer- and polymer-based modifications of adenovirus capsids for enhanced transduction of cancer cells
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities
Proton-sponge activity and receptor-targeting of sequence-defined nucleic acid carriers
Biocompatible and precise branched oligomers for pDNA and siRNA delivery
Targeted RNAi and pDNA based therapy for gastrointestinal tumors
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Treatment of cancer with combined chemo-gene therapy based on TNFα polyplexes and liposomal doxorubicine
Development of novel combinatorial treatment strategies to overcome resistance in breast cancer
Molecular imaging and radionuclide therapy in non-thyroidal tumors after mesenchymal stem cell- mediated sodium/iodide symporter (NIS) gene transfer
Molecularly targeted imaging and radionuclide therapy of non-thyroidal tumors following viral and non-viral sodium iodide symporter (NIS) gene delivery
Molecular evolution assays reveal novel targets and mechanisms of drug resistance
Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
Non-covalent dendrimer- and polymer-based modifications of adenovirus capsids for enhanced transduction of cancer cells
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities
Proton-sponge activity and receptor-targeting of sequence-defined nucleic acid carriers